The list of growth factors involved in tumor angiogenesis has grown substantially and includes vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), endostatin, ...
Researchers at Institute of Science Tokyo created a mouse model of the aggressive subtype of HCC and provided insights into its underlying molecular mechanism. Using these insights, they demonstrated ...
Copper complexes acting angiogenesis inhibitors have been disclosed in a patent from Istinye Universitesi and Karadeniz Teknik Universitesi Teknoloji Transferi Uygulama ve Arastirma Merkezi as ...
Intratumoral Injection of Dendritic Cells Engineered to Secrete Interleukin-12 by Recombinant Adenovirus in Patients With Metastatic Gastrointestinal Carcinomas Despite promising phase I and phase II ...
Thirty-six patients with advanced solid tumors were treated with various doses of AG-013736. In addition to standard measures of objective disease response and pharmacokinetic analysis, DCE-MRI scans ...
PHOTO CREDIT: Lori Desantis, Children's Hospital of Boston ANGIOGENESIS HONORS: Children's Hospital of Boston researcher Judah Folkman (far right) received the 1998 John Scott Award from the ...
The upregulation of PCSK9 expression in endothelial cells of diabetic patients induces ubiquitination of VEGFR2 and inhibits the VEGFR2/ AKT/eNOS -ERK signaling pathway by promoting the interaction of ...
Idorsia Pharmaceuticals Ltd. has reported the discovery of novel galectin-3 (Gal-3) inhibitors for the potential treatment of fibrotic and inflammatory diseases. Galactins are a family of ...